CLASS II ONGOING Device recall · Reported 26 Aug 2026 · FDA Enforcement Report

Siemens Healthineers Immulite 2000 Systems SYP Syphilis Screen recalled

Siemens Healthcare Diagnostics Products is recalling Siemens Healthineers Immulite 2000 Systems SYP Syphilis Screen, distributed nationwide in the US. The recall was initiated on 13 Jul 2026 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot Code: D387/UDI: 00630414976891
Quantity recalled24 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2965-2026
FDA event ID
99447
Recalling firm
Siemens Healthcare Diagnostics Products, Caernarfon
Classification
Class II
Status
Ongoing
Recall initiated
13 Jul 2026
FDA classified
14 Aug 2026
Reported
26 Aug 2026
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

13 Jul 2026Recall initiated by company
14 Aug 2026Classified by FDA+32 days
26 Aug 2026Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Syphilis Screen assay may contain a negative patient bias resulting in low reactive patient results being reported as nonreactive.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Siemens Healthineers Immulite 2000 Systems SYP Syphilis Screen REF:L2KSY2(D)/10471981 IVD, RxOnly

Where it was distributed

Worldwide - US Nationwide distribution in the states of FL, NJ, NY and the countries of Austria, Azerbaijan, Belgium, Brazil, Chile, Colombia, Cura-ao, St.¿Eus Cyprus, France, Germany, Italy, Kazakhstan, Latvia, Lithuania, Netherlands, Romania, Russian¿Fed., Saudi¿Arabia, Slovakia, Slovenia, South¿Africa, Spain, U.A.E., Ukraine, United¿Kingdom, Uzbekistan.¿¿¿¿¿

Nationwide FloridaNew JerseyNew York

Questions about this recall

Why was it recalled?

Syphilis Screen assay may contain a negative patient bias resulting in low reactive patient results being reported as nonreactive.

Which lots are affected?

Lot Code: D387/UDI: 00630414976891

Where was it sold?

Worldwide - US Nationwide distribution in the states of FL, NJ, NY and the countries of Austria, Azerbaijan, Belgium, Brazil, Chile, Colombia, Cura-ao, St.¿Eus Cyprus, France, Germany, Italy, Kazakhstan, Latvia, Lithuania, Netherlands, Romania, Russian¿Fed., Saudi¿Arabia, Slovakia, Slovenia, South¿Africa, Spain, U.A.E., Ukraine, United¿Kingdom, Uzbekistan.¿¿¿¿¿

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 99447

This product is part of a recall event; the main page for the event is Siemens Healthineers Immulite 2000 Systems SYP Syphilis Screen recalled.

More recalls from Siemens Healthcare Diagnostics Products

All 2

Other Other Medical Devices recalls

All 13,778